Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 with Nab-Paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
NCT02194829Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2014
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in pancreatic adenocarcinoma (PDAC), sponsored by National Cancer Institute. Started Aug 2014; status: completed.
02
Drugs
adavosertib
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02194829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194829.